Collegium Pharmaceutical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
CEOVikram Karnani
CEOVikram Karnani
Employees357
Employees357
HeadquartersStoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded2002
Founded2002
Employees357
Employees357
COLL Key Statistics
Market cap1.53B
Market cap1.53B
Price-Earnings ratio30.10
Price-Earnings ratio30.10
Dividend yield—
Dividend yield—
Average volume523.62K
Average volume523.62K
High today—
High today—
Low today—
Low today—
Open price$48.88
Open price$48.88
Volume301.00
Volume301.00
52 Week high$49.16
52 Week high$49.16
52 Week low$23.23
52 Week low$23.23
Stock Snapshot
Collegium Pharmaceutical(COLL) stock is priced at $48.85, giving the company a market capitalization of 1.53B. It carries a P/E multiple of 30.10.
On 2025-12-12, Collegium Pharmaceutical(COLL) shares started trading at $48.88, with intraday highs of — and lows of —.
Trading activity shows a volume of 301, compared to an average daily volume of 523.62K.
Over the past 52 weeks, Collegium Pharmaceutical(COLL) stock has traded between a high of $49.16 and a low of $23.23.
Over the past 52 weeks, Collegium Pharmaceutical(COLL) stock has traded between a high of $49.16 and a low of $23.23.
COLL News
Simply Wall St 6d
Collegium Pharmaceutical: Assessing Valuation After Earnings Beats, Strong Zacks Rating and Value Investor InterestCollegium Pharmaceutical (COLL) has jumped onto investors radars after a streak of earnings beats and a top research rating, with that momentum helping push the...
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.